Vimarsana
Biggest News Aggregation in the World

Biogen Digital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biogen Digital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biogen Digital Today - Breaking & Trending Today

Biogen Inc.: Biogen Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with MS - Vimarsana News

Biogen Inc.: Biogen Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with MS

Data demonstrate potential of Manual Dexterity Test and Konectom smartphone-based technology in measuring MS disease progressionRetrospective analysis applying machine learning, artificial intelligence

Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis - Vimarsana News

Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis

The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on Rhythmic Auditory Stimulation MedRhythms to receive a $3 million upfront payment... | May 5, 2022

Biogen Inc.: Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis - Vimarsana News

Biogen Inc.: Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis

The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on Rhythmic Auditory Stimulation (RAS)MedRhythms to receive a $3 million upfront payment as

Digital Medicine Society Launches Toolkit to Support Reimbursement for New Drugs Developed Using Digital Endpoints - Vimarsana News

Digital Medicine Society Launches Toolkit to Support Reimbursement for New Drugs Developed Using Digital Endpoints

/PRNewswire/ -- Today, the Digital Medicine Society (DiMe), in partnership with Anthem, Biogen, Eli Lilly, Evidation, Janssen, Merck, Pfizer, and Savvy Co-op,...

Biogen Inc.: New Data at AAN 2022 Highlight Real-World Evidence from Biogen's MS Portfolio and Emerging Research on Disease Progression - Vimarsana News

Biogen Inc.: New Data at AAN 2022 Highlight Real-World Evidence from Biogen's MS Portfolio and Emerging Research on Disease Progression

Data from NOVA study further support the efficacy and safety of natalizumab IV when administered every six weeks as compared to the approved every four-week dosingAdditional real-world data affirm high